Obstetrics & Gynecology Email Alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Obstetrics & Gynecology 2001;98:853-860
© 2001 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dickinson, B. D.
Right arrow Articles by Sterling, M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dickinson, B. D.
Right arrow Articles by Sterling, M. L.

REVIEW

Drug Interactions Between Oral Contraceptives and Antibiotics

Barry D. Dickinson, PhD, Roy D. Altman, MD, Nancy H. Nielsen, MD, PhD and Melvyn L. Sterling, MD for the Council on Scientific Affairs, American Medical Association

From the Council on Scientific Affairs, American Medical Association, Chicago, Illinois.

Address reprint requests to: Barry Dickinson, PhD, Secretary to the Council on Scientific Affairs, American Medical Association, 515 North State Street, Chicago, IL 60610; E-mail: barry_dickinson{at}ama-assn.org.

OBJECTIVE: To evaluate the evidence on possible drug interactions between antibiotics and oral contraceptives (OCs) that may lead to OC failure.

DATA SOURCES: MEDLINE and Lexis/Nexis Medical Library searches for 1966–1999 using the key word "oral contraceptives," cross-indexed with the terms "antibiotics," "adverse effects," and "pregnancy," and MEDLINE search using the additional MeSH term "drug interactions." No language restrictions were used.

METHODS OF STUDY SELECTION: A total of 167 articles were retrieved for analysis. Another 32 articles were identified by review of the references cited in these publications. Articles were selected based on their ability to provide information on the relationship between antibiotic therapy and OC efficacy in otherwise compliant users (defined as women with unplanned pregnancies who reported compliance with their OC regimen). Additionally, studies that either directly measured the effects of antibiotics on the pharmacokinetics of OC components, or that analyzed the effects of antibiotics on measures of ovulation in OC users were accepted.

TABULATION, INTEGRATION, AND RESULTS: At least 30 cases have been reported of pregnancies occurring in women taking OCs and antibiotics, particularly rifampin. Approximately 20% of pregnant women reporting to family planning or abortion clinics reported concomitant OC and antibiotic use. Information from adverse event reporting databases generally mirrors the types of information gleaned from these case reports and clinical surveys and accounts for approximately one-third of reported cases. Retrospective surveys, primarily from dermatology-based practices, also have reported 24 pregnancies in OC users who concomitantly received therapy with antibiotics, most commonly tetracyclines and penicillins. Apparent OC failure rates in clinical surveys were within the usual range expected for patterns of typical use. In pooled results obtained from relatively small populations, oral antibiotics, with the exception of rifampin, have not significantly affected the pharmacokinetics of ethinyl estradiol, levonorgestrel, and norethindrone or reduced the serum concentrations of gonadotropins. However, individual patients have been identified who experienced significant decreases in the plasma concentration of these components of OCs and who appeared to ovulate.

CONCLUSION: Rifampin impairs the effectiveness of OCs. Pharmacokinetic studies of other antibiotics have not shown any systematic interaction between antibiotics and OC steroids. However, individual patients do show large decreases in the plasma concentrations of ethinyl estradiol when they take certain other antibiotics, notably tetracycline and penicillin derivatives. Because it is not possible to identify these women in advance, a cautious approach is advised.




This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
M. Shou, M. Hayashi, Y. Pan, Y. Xu, K. Morrissey, L. Xu, and G. L. Skiles
Modeling, Prediction, and in Vitro in Vivo Correlation of CYP3A4 Induction
Drug Metab. Dispos., November 1, 2008; 36(11): 2355 - 2370.
[Abstract] [Full Text] [PDF]


Home page
Pediatr. Rev.Home page
D. P. Krowchuk
Managing Adolescent Acne: A Guide for Pediatricians
Pediatr. Rev., July 1, 2005; 26(7): 250 - 261.
[Full Text] [PDF]


Home page
NEJMHome page
W. D. James
Acne
N. Engl. J. Med., April 7, 2005; 352(14): 1463 - 1472.
[Full Text] [PDF]


Home page
Sex. Transm. Infect.Home page
H S Mitchell and E Stephens
Contraception choice for HIV positive women
Sex Transm Inf, June 1, 2004; 80(3): 167 - 173.
[Abstract] [Full Text] [PDF]


Home page
Obstet GynecolHome page
J. L. Lindsey, M. Hugin, R. D. Altman, N. H. Nielsen, M. L. Sterling, and B. D. Dickinson
Drug Interactions Between Oral Contraceptives and Antibiotics
Obstet. Gynecol., May 1, 2002; 99(5): 841 - 842.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American College of Obstetricians and Gynecologists.